Recaticimab - Research Grade Biosimilar, CAS [[2361290-85-7]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-957
Artikelname: |
Recaticimab - Research Grade Biosimilar, CAS [[2361290-85-7]], Unconjugated, Monoclonal |
Artikelnummer: |
PRS-21-957 |
Hersteller Artikelnummer: |
21-957 |
Alternativnummer: |
PRS-21-957-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Humanized / PCSK9 |
Konjugation: |
Unconjugated |
Alternative Synonym: |
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEINE CONVERTASE 9, PC9)), MONOCLONAL ANTIBODY (RECATICIMAB) RECATICIMAB RECATICIMAB [INN], FH3 |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
NCBI: |
255738 |
UniProt: |
Q8NBP7 |
Puffer: |
PBS buffer pH 7.5 |
Quelle: |
CHO cells |
Reinheit: |
>95% |
CAS Nummer: |
[2361290-85-7] |
Application Verdünnung: |
For research use only . |